企業プロフィール
ResMed 株価・ニュース・カタリスト
- ティッカー:
- RMD
- 取引所:
- NYSE
- セクター:
- MedTech
- 所在地:
- United States
株価パフォーマンス
220.37 USD (-1.82%)
終値
最終更新: 2026年8月17日
26.5B USD
時価総額
株価変動の要因
As of Aug 17, 2026, RMD closed down 1.82% at $220.37. No new same-company headline was identified in the current news window.
企業概要
事業概要
ResMed is a medical device and digital health company focused on sleep apnea, respiratory care, and related connected-health solutions. Its business is built around device usage, recurring supplies, and software-enabled care delivery.
所在地とセクター分類
Headquartered in the United States and listed on NYSE, ResMed has a global healthcare footprint. It sits in medtech and digital health rather than therapeutic biotech.
ビジネスモデルの特徴
The company generates revenue from PAP devices, masks, accessories, and connected-care services. Investors watch device adoption, sleep market demand, and the balance between recurring supplies and new product growth.
バイオ業界での位置付け
ResMed is outside biotech but important in healthcare technology because of its recurring device model. It moves on procedure and chronic-care demand rather than on clinical-trial catalysts.
今後のカタリスト
- ResMed’s catalysts are sleep-apnea device growth, GLP-1-driven OSA awareness, and continued software / patient-care platform expansion. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。